Benzyl Isothiocyanate Pretreatment Enhances Chemoradiation Response in HPV-Negative Head and Neck Squamous Cell Carcinoma
International Journal of Molecular Sciences · 07.11.2026 · 27 (21) · 9990
DOI: 10.3390/ijms27219990 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 07.11.2026. Verfasst von Imani A Kirven und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology & Toxicology, University of Mississippi Medical Center, Jackson, MS 39216, USA. Hauptthemen laut MEDLINE: Isothiocyanates, Chemoradiotherapy, Squamous Cell Carcinoma of Head and Neck, Head and Neck Neoplasms. Die Arbeit nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIH HHS, National Institutes of Health.
Abstract (Originalsprache)
Head and neck squamous cell carcinoma (HNSCC) accounts for ~3% of U.S. cancer diagnoses, and many patients present with locally or regionally advanced disease. Despite multimodal standard-of-care (SOC) treatment, the median overall survival for recurrent or metastatic disease remains ~12 months. Acquired resistance to cisplatin (CDDP) and radiotherapy (RT) remains a central barrier to durable response, motivating neoadjuvant strategies to improve efficacy in resistant tumors. Benzyl isothiocyanate (BITC) is a dietary phytochemical with selective anticancer activity. Across four patient-matched HNSCC cell lines spanning a range of intrinsic sensitivities to CDDP or RT, pretreatment with BITC before RT and CDDP significantly increased HNSCC cell death as measured by caspase-3/7 activity, regardless of each cell line’s single-agent sensitivity. Within 24 h, BITC elevated cytoplasmic ROS across all lines: BITC-resistant cell lines countered this with a more robust increase in the GSH/GSSG ratio and retained viability, whereas the BITC-sensitive lines mounted a weaker glutathione (GSH) response and required rescue with exogenous GSH or N-acetylcysteine (NAC), indicating redox-sensitive cytotoxicity. Transcriptomic time-course analysis suggested that BITC induces a coordinated stress response, including proteotoxic HSF1 activation, and suppresses DNA replication and homologous recombination repair, thereby supporting a transcriptional basis for the observed sensitization to DNA-damaging therapy. By enhancing the efficacy of RT and CDDP in HPV-negative HNSCC, BITC may be a promising neoadjuvant strategy to improve the therapeutic index of chemotherapy and radiation in these patients, warranting further investigation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmacology & Toxicology, University of Mississippi Medical Center, Jackson, MS 39216, USA.
- Department of Otolaryngology-Head & Neck Surgery, University of Mississippi Medical Center, Jackson, MS 39216, USA.
- Department of Radiation Oncology, School of Medicine, University of Mississippi Medical Center, Jackson, MS 39216, USA.
- Department of Clinical and Experimental Medicine, University of Foggia, 71122 Foggia, Italy.
ORCID-Profile: Patrice Penfornis, Gina D Jefferson, Lorenzo Lo Muzio, Pier Paolo Claudio
Förderung
- NIH HHS
- National Institutes of Health
Zitieren
APA
Kirven, I. A., Penfornis, P., Eastham, L. L., Jefferson, G. D., Yang, C., Duggar, W. N., Jacob, R., Lo Muzio, L., & Claudio, P. P. (2026). Benzyl Isothiocyanate Pretreatment Enhances Chemoradiation Response in HPV-Negative Head and Neck Squamous Cell Carcinoma. International Journal of Molecular Sciences, 27(21), 9990. https://doi.org/10.3390/ijms27219990
Vancouver
Kirven IA, Penfornis P, Eastham LL, Jefferson GD, Yang C, Duggar WN, et al. Benzyl Isothiocyanate Pretreatment Enhances Chemoradiation Response in HPV-Negative Head and Neck Squamous Cell Carcinoma. International Journal of Molecular Sciences. 2026;27(21):9990. doi:10.3390/ijms27219990
BibTeX
@article{Kirven2026,
author = {Kirven, Imani A and Penfornis, Patrice and Eastham, Linda L and Jefferson, Gina D and Yang, Chunli and Duggar, William N and Jacob, Rojymon and Lo Muzio, Lorenzo and Claudio, Pier Paolo},
title = {Benzyl Isothiocyanate Pretreatment Enhances Chemoradiation Response in HPV-Negative Head and Neck Squamous Cell Carcinoma},
journal = {International Journal of Molecular Sciences},
year = {2026},
volume = {27},
number = {21},
pages = {9990},
doi = {10.3390/ijms27219990}
}
EUVIMED